NeoGenomics completes acquisition of Path Logic
NeoGenomics, a provider of cancer-focused genetic testing services, has acquired Path Labs (Path Logic). Path Logic is a provider of specialized anatomic pathology services to hospitals and physicians in Northern California. Path Logic provides anatomic pathology services with experience in renal pathology, dermatopathology, women's health and gastrointestinal and genitourinary pathology.
For 2013, Path Logic reported revenue of approximately $10 million and had approximately 65 employees. The acquisition purchase price was $6 million. The transaction includes Path Logic's main laboratory in West Sacramento, Calif., as well as satellite facilities in Santa Ana and Fresno, Calif. Path Logic will operate as a wholly owned subsidiary of NeoGenomics to provide specialized anatomic pathology services for NeoGenomics' clinical trials and pathology clients across the country.